Serinus Biosciences is focused on designing next-generation precision medicine drugs targeting treatment-resistant cancer patients. Their innovative AI platform, Res Cu ETM, identifies druggable vulnerabilities induced by tumor resistance mechanisms, allowing for the development of effective treatments for patients with no therapeutic alternatives. By mapping resistance mechanisms and leveraging synthetic lethality principles, Serinus aims to overcome the significant challenges in drug development for cancer, positioning itself as a leader in the oncology space with a commitment to rigorous science and patient-first values.

New York, NY, USA

Serinus Biosciences

Vertex Ventures Israel

Tell us about your professional DNA to get discovered by any company in our network with opportunities relevant to your career goals.

Leverage our network to build your career.

#### Welcome!

Thank you for joining Vertex Ventures Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Vertex Ventures network as they come up.

You can always update this information later.

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Vertex Ventures company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Explore open opportunities in our portfolio companies